Immunodeficiency
Research on immunodeficiency discussed by S. Fransen and co-researchers
Published in AIDS Weekly, December 14th, 2009
"The human immunodeficiency virus type 1 (HIV-1) integrase mutations N155H and Q148R(H)(K) that reduce susceptibility to the integrase inhibitor raltegravir have been identified in patients failing treatment regimens containing raltegravir. Whether these resistance mutations occur individually or in combination within a single virus genome has not been defined, nor do we fully understand the impact of these primary mutations and other secondary mutations on raltegravir susceptibility and viral replication capacity," scientists writing in the Journal of Virology report.
"To address these important questions, we investigated the raltegravir susceptibility and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2009-12-14)
More Articles from AIDS Weekly
- McGill University Health Centre
Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria - McGill University Health Centre
Tuberculosis: On the path to prevention - University of Cincinnati Academic Health Center
Some patients diagnosed with HIV experience improved outlook on life - University of Toronto
Availability of vaccine no guarantee public will want it - Antiretroviral
Studies from L.P.V. Cardoso and co-researchers update current data on antiretroviral - Bioengineering
Researchers at Jinan University target bioengineering - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
